Association of impaired kidney function with mortality in rural Uganda: results of a general population cohort study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
26 04 2022
Historique:
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 29 4 2022
Statut: epublish

Résumé

To determine the association between baseline kidney function and subsequent all-cause mortality. A general population-based cohort study from rural Uganda. People aged 18 years and above with measured baseline estimated glomerular filtration rate (eGFR), recruited from survey rounds in 2011-2012 or 2014-2015 and followed up to March 2019. The primary outcome was all-cause mortality, identified through reports from community health workers and verified by verbal autopsy. The association between baseline eGFR category and mortality was determined using multivariable Cox regression. Of 5812 participants in both rounds, we included 5678 (97.7%) participants with kidney function and mortality data; the median age was 36 years (IQR 24-50), 60.7% were female, 10.3% were hypertensive, 9.8% were HIV-positive and 1.5% were diabetic. During a median follow-up of 5.0 years (IQR 3.7-6.0) there were 140 deaths. In age-adjusted and sex-adjusted analyses, eGFR <45 mL/min/1.73 m In a prospective cohort in rural Uganda we found that impaired baseline kidney function was associated with subsequently increased total mortality. Improved understanding of the determinants of kidney disease and its progression is needed in order to inform interventions for prevention and treatment.

Identifiants

pubmed: 35473721
pii: bmjopen-2021-051267
doi: 10.1136/bmjopen-2021-051267
pmc: PMC9045120
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e051267

Subventions

Organisme : Medical Research Council
ID : MC_UU_00027/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

PLoS One. 2019 May 14;14(5):e0216060
pubmed: 31086371
PLoS One. 2015 Sep 25;10(9):e0138991
pubmed: 26406462
Am J Nephrol. 2011;34(4):330-6
pubmed: 21860228
Kidney Int. 2017 Oct;92(4):793-795
pubmed: 28938952
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045
pubmed: 28522654
BMC Med. 2019 May 21;17(1):98
pubmed: 31109328
J Virol Methods. 2013 Sep;192(1-2):25-7
pubmed: 23583487
Lancet Glob Health. 2017 Apr;5(4):e408-e417
pubmed: 28229924
Am J Hypertens. 2014 Jun;27(6):811-8
pubmed: 24515804
PLoS Med. 2007 Nov 20;4(11):e327
pubmed: 18031196
Am J Kidney Dis. 2017 Oct;70(4):586
pubmed: 28807401
J Hum Hypertens. 1999 Jan;13(1):37-40
pubmed: 9928750
Lancet. 2015 May 16;385(9981):1975-82
pubmed: 25777665
Am J Kidney Dis. 2014 May;63(5):713-35
pubmed: 24647050
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
BMC Nephrol. 2015 Jan 16;16:4
pubmed: 25592556
Kidney Int. 2018 Mar;93(3):545-559
pubmed: 29398134
Hypertension. 2003 Nov;42(5):1050-65
pubmed: 14604997
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):458-63
pubmed: 26712016
Wellcome Open Res. 2019 Jun 10;4:92
pubmed: 31656860
Int J Epidemiol. 2013 Feb;42(1):129-41
pubmed: 23364209
Lancet Glob Health. 2016 Apr;4(4):e242-50
pubmed: 27013312
Clin J Am Soc Nephrol. 2011 Apr;6(4):906-12
pubmed: 21441133
PLoS One. 2018 Mar 02;13(3):e0193384
pubmed: 29499039
Am J Nephrol. 2021;52(2):98-107
pubmed: 33752206
Clin Chem. 2006 Jan;52(1):5-18
pubmed: 16332993
Lancet. 2020 Feb 29;395(10225):709-733
pubmed: 32061315
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
PLoS One. 2017 Jun 1;12(6):e0177460
pubmed: 28570592
Wellcome Open Res. 2018 Nov 19;3:149
pubmed: 31223661
Clin Kidney J. 2019 Aug 19;12(6):778-787
pubmed: 31807291
Cardiovasc J Afr. 2015 Jul-Aug;26(4):177-80
pubmed: 26407219
Lancet Glob Health. 2014 Mar;2(3):e174-81
pubmed: 25102850
AIDS. 2008 Sep 12;22(14):1821-7
pubmed: 18753939
Lancet Glob Health. 2019 Dec;7(12):e1632-e1643
pubmed: 31708144

Auteurs

Robert Kalyesubula (R)

Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK rkalyesubula@gmail.com.
Physiology and Internal Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Non-Communicable Disease Epidemiology, MRC/UVRI and LSHTM Research Unit, Entebbe, Uganda.

Isaac Sekitoleko (I)

Non-Communicable Disease Epidemiology, MRC/UVRI and LSHTM Research Unit, Entebbe, Uganda.

Keith Tomlin (K)

Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.

Christian Holm Hansen (CH)

Infectious Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Billy Ssebunya (B)

Non-Communicable Disease Epidemiology, MRC/UVRI and LSHTM Research Unit, Entebbe, Uganda.

Ronald Makanga (R)

Non-Communicable Disease Epidemiology, MRC/UVRI and LSHTM Research Unit, Entebbe, Uganda.

Moses Kwizera Mbonye (MK)

Non-Communicable Disease Epidemiology, MRC/UVRI and LSHTM Research Unit, Entebbe, Uganda.

Janet Seeley (J)

Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.

Liam Smeeth (L)

Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.

Robert Newton (R)

Non-Communicable Disease Epidemiology, MRC/UVRI and LSHTM Research Unit, Entebbe, Uganda.
Department of Health Sciences, University of York, York, UK.

Laurie A Tomlinson (LA)

Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH